+634.5%
MRNA vs VEEV
+182.6%
+451.9%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | VEEV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | +0.1% | +0.7% | +0.7% |
| 7D | -8.2% | -8.2% | 0.0% | -4.7% |
| 30D | +125.6% | +10.3% | +115.2% | +115.6% |
| 3M | +197.1% | +59.4% | +137.7% | +143.9% |
| 6M | +148.5% | +37.6% | +110.9% | +114.1% |
| YTD | +363.3% | +16.9% | +346.4% | +325.7% |
| 1Y | +462.0% | -5.0% | +467.0% | +458.1% |
| 3Y | +26.9% | +18.5% | +8.5% | +12.4% |
| 5Y | -69.6% | -13.8% | -55.8% | -71.1% |
| All | +634.5% | +182.6% | +451.9% | +322.1% |
Cumulative growth
Daily Returns
Daily percentage return beside VEEV.
Daily Out/Under-Performance
Portfolio return minus VEEV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VEEV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded VEEV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling